Madrigal Pharmaceuticals, Inc. (MDGL)
523.69
-16.20
(-3.00%)
USD |
NASDAQ |
May 15, 16:00
524.10
+0.41
(+0.08%)
After-Hours: 20:00
Madrigal Pharmaceuticals Shareholders Equity (Quarterly) : 543.45M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 704.85M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| PTC Therapeutics, Inc. | -180.46M |
| Protagonist Therapeutics, Inc. | 655.47M |
| Altimmune, Inc. | 283.99M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.227B |
| Total Liabilities (Quarterly) | 683.87M |
| Debt to Equity Ratio | 0.6391 |
| Current Ratio | 3.495 |
| Net Debt Paydown Yield | -0.38% |